Form D · Other
Cortex, Inc.
Menlo Park, CA · CIK 0002002107
Offering snapshot reported Dec 7, 2023 · SEC filing
- Reported sold
- $133M Offering amount: $223M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2023 | Initial | $133,400,250 | No comparison | 47 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-499065
Source: Form D, filed Dec 7, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Satvat Ali | Director |
| Adam Halpern Leistner | Director |
| Joe Koblish | Executive |
| Melissa Kong | Executive |
| Doug Koo | Executive |
| Avi Naider | Director |
| Duke Rohlen | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
C/O Ajax Health 650 Live Oak Avenue, Suite 100
Menlo Park, CA, 94025
Menlo Park, CA, 94025